Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024
-- Amarin to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024 --
- Cash Position: Amarin ended 2023 with approximately $321 million in cash and investments, with positive cash flow of approximately $10 million for the full year.
- “In 2023, our team focused and delivered on our priorities that advanced our strategy,” said Patrick Holt, President & CEO of Amarin.
- Amarin delivered approximately 65% growth in the fourth quarter versus the third quarter 2023.
- Amarin anticipates that these steps could be completed by the end of the second quarter of 2024, with share repurchases commencing shortly thereafter.